ECCO 2018 European Cancer Summit 12/06/2018
The ECCO 2018 European Cancer Summit will take place on 7-9 September 2018, at the Austria Center Vienna in Vienna, providing a focal point for resolution on the burning matters affecting access to high quality cancer care for patients across Europe.
Healthcare resources allocated to cancer vary substantially by country and there is an urgent need to address this burning issue. What are the optimal approaches, and could it be possible to apply a harmonised approach across different domains?
Represent your organisation’s voice to the change-making community of European cancer care and drive the debate on outcomes research, health economics and organisation of cancer care delivery at ECCO 2018 European Cancer Summit in Vienna.
Improving efficiency in cancer care: how can multidisciplinarity make a difference?
The session will:
- Highlight latest research from All.Can on patient experience and perspective in respect to inefficiency in cancer care and opportunities for improvement
- Explore the role of multidisciplinary cancer care in addressing inefficiency in cancer care (e.g. reducing delays and unnecessary interventions, and improving outcomes)
- Share early work by the Innovative Partnership on Action against Cancer (iPAAC) on meeting the challenge of waste and inefficiency in cancer care across Europe
- Reflect on conclusions from 2018 research on waste and inefficiency in cancer care by the Swedish Institute for Health Economics (IHE)
Kathy Oliver, International Brain Tumour Alliance, UK
Prof Bengt Jonsson, Stockholm School of Economics, Sweden
Prof Martine Piccart, Institut Jules Bordet, Belgium
Amadou Diarra, Global VP Policy Advocacy & Government Affairs, Bristol-Myers Squibb, USA
Dr Monica Bertagnolli, ASCO President-Elect, USA
Access and Value: It's about the entire cancer pathway
Those involved in cancer care know well the transformative impact of non-pharmaceutical treatments and care. Improving patient outcomes is about so much more than new medicines. Yet this does not seem adequately reflected in the current access debate.
The session will:
- Examine the potential for applying scales for assessing value in the pharmaceutical domain to innovations in the non-systemic treatment sector (e.g. surgery and radiation oncology)
Session moderator: Prof Richard Sullivan
Concluding remarks: Prof Philip Poortmans, ECCO President
Prof Yolande Lievens, European Society for Radiotherapy and Oncology (ESTRO)
Dr Ajay Aggarwal, Institute of Cancer Policy, King’s College London
Prof Riccardo Audisio, Sahlgrenska University Hospital, Gothenburg
- Examine how the role of professional care to cancer patients, and other interventions, can be better valued and recognised within national health systems.
Prof Lorenzo Derchi, European Society of Radiology (ESR)
Prof Andreas Charalambous, European Oncology Nursing Society (EONS)
Dr Maria Die Trill, International Psycho-Oncology Society (IPOS)
The deadline for regular rate registration is 3rd September 2018.
Together let’s help shape a new and ambitious future for the oncology community! #ECCOSummit